{"id":"W4406104381","doi":"10.1038/s41591-024-03334-7","title":"Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; National Center for Advancing Translational Sciences; Cancer Center, University of Colorado; University of California, San Francisco; Queen Mary University of London; Weill Cornell Medical College; Genentech; Centro de Investigación Biomédica en Red de Cáncer; Universidad de Navarra; Memorial Sloan-Kettering Cancer Center; University of Washington; Uppsala Universitet; Universiteit Gent; Johannes Gutenberg-Universität Mainz; University of Oklahoma Health Sciences Center; Universitair Ziekenhuis Gent; University of Southampton; Seagen; Akademiska Sjukhuset; Cedars-Sinai Medical Center; University of Oklahoma; Massachusetts General Hospital; National Cancer Institute; Gilead Sciences; Yale University; University Hospital Southampton NHS Foundation Trust; Deutsches Krebsforschungszentrum; Universitätsmedizin der Johannes Gutenberg-Universität Mainz; Yale Cancer Center","keywords":"Atezolizumab; Medicine; Immunogenicity; Tolerability; Immunotherapy; CD8; Oncology; Internal medicine; Immunology; Cancer; Immune system; Pembrolizumab; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004135159,0.0003170846,0.0008443511,0.0004504795,0.0001451583,0.000007294128,0.0003166941,0.0005284544,0.0009011996],"category_scores_gemma":[0.0004031963,0.0001847656,0.00006075854,0.0006997617,0.0003817875,0.000090627,0.00003713472,0.001200682,0.00003108157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000843642,"about_ca_system_score_gemma":0.0003707044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009376586,"about_ca_topic_score_gemma":0.0001433307,"domain_scores_codex":[0.998243,0.000298457,0.0005202218,0.0003981895,0.00007465789,0.0004655291],"domain_scores_gemma":[0.9990028,0.0002876643,0.000148761,0.0004507257,0.00009022436,0.00001981503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5136052,0.0005453184,0.0001996115,0.00004130972,0.0003043189,0.0000777253,0.0008829213,0.000002557361,0.4375434,0.000255176,0.001825712,0.04471679],"study_design_scores_gemma":[0.4868521,0.009930983,0.001342219,0.001625046,0.0001340341,0.0002276884,0.0008133506,0.00001243758,0.262139,0.00008994423,0.2364226,0.0004105627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9574814,0.03557858,0.0001593872,0.002241537,0.001744955,0.001068606,0.0000101752,0.000116026,0.001599294],"genre_scores_gemma":[0.9808558,0.0003686541,0.00008483054,0.001583604,0.00009248484,0.0001072116,0.00009100032,0.00002511161,0.0167913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2345969,"threshold_uncertainty_score":0.9867504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009365711283726631,"score_gpt":0.3398104727478319,"score_spread":0.3304447614641052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}